Janus Henderson Group PLC Decreases Holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Janus Henderson Group PLC lessened its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 43.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,846,859 shares of the real estate investment trust's stock after selling 2,200,656 shares during the quarter. Janus Henderson Group PLC owned about 1.20% of Sabra Health Care REIT worth $52,940,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Family Firm Inc. acquired a new stake in shares of Sabra Health Care REIT during the 2nd quarter worth approximately $26,000. Assetmark Inc. increased its holdings in Sabra Health Care REIT by 168.4% in the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust's stock worth $37,000 after acquiring an additional 1,231 shares during the last quarter. GAMMA Investing LLC raised its holdings in Sabra Health Care REIT by 40.0% during the 2nd quarter. GAMMA Investing LLC now owns 3,682 shares of the real estate investment trust's stock valued at $57,000 after acquiring an additional 1,052 shares during the period. Harbor Capital Advisors Inc. purchased a new position in Sabra Health Care REIT during the 3rd quarter valued at about $78,000. Finally, International Assets Investment Management LLC increased its holdings in Sabra Health Care REIT by 1,761.0% during the 3rd quarter. International Assets Investment Management LLC now owns 6,104 shares of the real estate investment trust's stock worth $114,000 after acquiring an additional 5,776 shares during the period. 99.40% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on SBRA shares. Truist Financial increased their price target on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Wells Fargo & Company raised Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and increased their price objective for the company from $16.00 to $20.00 in a research report on Tuesday, October 1st. Scotiabank raised their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a report on Friday, October 11th. Citigroup raised Sabra Health Care REIT from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $17.00 to $20.00 in a research note on Friday, September 13th. Finally, Mizuho reaffirmed a "neutral" rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research note on Thursday. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $19.14.

Sabra Health Care REIT Stock Performance

Shares of NASDAQ:SBRA traded down $0.22 on Friday, hitting $18.04. 2,193,827 shares of the company were exchanged, compared to its average volume of 2,037,716. Sabra Health Care REIT, Inc. has a 1-year low of $12.83 and a 1-year high of $20.03. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90. The firm has a market capitalization of $4.27 billion, a P/E ratio of 43.64, a price-to-earnings-growth ratio of 2.32 and a beta of 1.24. The stock's 50 day moving average price is $18.60 and its 200 day moving average price is $16.93.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing analysts' consensus estimates of $0.35 by ($0.22). The company had revenue of $178.00 million for the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same quarter in the prior year, the company posted $0.34 earnings per share. Sell-side analysts predict that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 29th. Shareholders of record on Friday, November 15th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.65%. The ex-dividend date of this dividend was Friday, November 15th. Sabra Health Care REIT's dividend payout ratio is currently 292.69%.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.